Bayer previously asked that the lawsuit be dismissed - but John Padova, U.S. District Judge in Philadelphia, has ruled that claims made by two particular women signify legitimate misleading advertising, essentially failing to provide information about certain risks.
Bayer Healthcare and Johns Hopkins University are collaborating to develop therapy targeting retinal diseases, GSK is investing in a cell research institute.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The American Society of Clinical Oncology‘s effort to use big data and EHRs to earlier detect cancer just got a $1 million boost from pharma giant Bayer Healthcare. The Society, better known as ASCO, recently launched the effort dubbed CancerLinQ with Germany-based SAP, creating what’s described as an IT platform “designed to unlock vast quantities […]
Bay Area venture capital firm Versant Ventures has teamed up with Bayer HealthCare to create a new fund that invest in biotech and medical device companies that target unmet medical needs. Bayer’s contributing up to $25 million to Versant Venture Capital V, though it’s only one of several investors to make up the fund, the companies said in a […]